Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart procedure could ease symptoms of heart failure

NCT ID NCT07403058

First seen Feb 23, 2026 · Last updated May 18, 2026 · Updated 9 times

Summary

This early-stage trial tests a catheter-based procedure that targets a nerve near the heart to see if it can safely improve symptoms in people with heart failure with reduced ejection fraction (HFrEF). Up to 50 patients aged 40 or older will be randomly assigned to receive either the real treatment or a sham procedure, and neither they nor their heart doctor will know which they got. The main goals are to check safety and look for early signs of benefit, not to prove long-term effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Clínico Universitario de Valencia-INCLIVA

    Valencia, Spain

  • King's College London

    London, United Kingdom

  • Leeds General Infirmary

    Leeds, United Kingdom

  • Motol and Homolka University Hospital

    Prague, Czechia

  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wrocławiu

    Wroclaw, Poland

  • Vithas Valencia Turia

    Valencia, Spain

Conditions

Explore the condition pages connected to this study.